Business
Kite is developing a CAR-T, or chimeric antigen receptor T-cell therapy, which harnesses the body's immune cells to recognize and attack malignant cells.
Hi, what are you looking for?
Kite is developing a CAR-T, or chimeric antigen receptor T-cell therapy, which harnesses the body's immune cells to recognize and attack malignant cells.
Flytrex is among the first to overcome regulatory restrictions and to carry out a shipment with a drone that comes out of the sight...
Artificial Intelligence bots, Bob and Alice, started using their language to complete a conversation. “I can i i everything else,” Bob said. “Balls have...
Kuwait submitted to Qatar a list of requirements for ending the declared boycott. The Associated Press published the document in which the conditions appear:...
Soros: 'Economic reality is reinforced by political reality. The fact is that Brexit is a lose-lose proposition, harmful both to Britain and the European...
Hotelier Ian Schrager says: "Time change. People change. Everything changes - hotels have not." The 'Public Hotel' is Schrager' new experiment.
Chinese Hainan Airlines agree to open a new route between Shanghai-Tel Aviv and add one more flight Tel Aviv-Beijing in September.
Emil Michael, Uber Technologies' chief business officer, one of CEO Travis Kalanick's closest allies, may leave Uber permanently or take a leave of absence,
US president told Abbas his team is studying a new peace initiative which reportedly to include discussions on each core issue separately.
German-Israeli researchers restore the memory performance of lab mice to a juvenile stage. Clinical trials on humans are next.